Abstract
Virus-like particles (VLPs) have vast potential for applications in nanoscience and nanomedicine. These biological nanoparticles may be used for medical imaging, vaccination, or tissue-specific delivery of drugs or other bioactive molecules. VLPs of Human parvovirus B19 (B19 V) can be assembled in vitro from the recombinant VP2 protein. In this research, we describe a simple method for the encapsulation of heterologous linear dsDNA fragments of different sizes into B19 V-VP2 VLPs, in which the DNA and denatured VP2 protein are co-incubated and the assembly process is conducted by one dialysis step. Characterization of the particles by qPCR demonstrated the encapsulation of dsDNA, and indicates that the length of the dsDNA is critical for the encapsulation process. The strategy presented here opens the possibility to use this VLPs as a delivery system with future therapeutically applications.
Similar content being viewed by others
References
Zhao, L., Seth, A., Wibowo, N., Zhao, C. X., Mitter, N., Yu, C., et al. (2014). Nanoparticle vaccines. Vaccine, 32, 327–337.
Wang, Q., Lin, T., Tang, L., Johnson, J. E., & Finn, M. G. (2002). Icosahedral virus particles as addressable nanoscale building blocks. Angewandte Chemie International Edition, 41, 459–462.
Steinmetz, N. F., & Evans, D. J. (2007). Utilization of plant viruses in bionanotechnology. Organic & Biomolecular Chemistry, 5, 2891–2902.
Manchester, M., & Singh, P. (2006). Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging. Advanced Drug Delivery Reviews, 58, 1505–1522.
Huang, X., Bronstein, L. M., Retrum, J., Dufort, C., Tsvetkova, I., Aniagyei, S., et al. (2007). Self-assembled virus-like particles with magnetic cores. Nano Letters, 7, 2407–2416.
Nam, K. T., Kim, D. W., Yoo, P. J., Chiang, C. Y., Meethong, N., Hammond, P. T., et al. (2006). Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes. Science, 312, 885–888.
Zeltnis, A. (2013). Construction and characterization of virus-like particles: A review. Molecular Biotechnology, 53, 92–107.
Yoo, J. W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011). Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nature Reviews Drug Discovery, 10, 521–535.
Stanley, S. (2014). Biological nanoparticles and their influence on organisms. Current Opinion in Biotechnology, 28, 69–74.
Pattenden, L. K., Middelberg, A. P., Niebert, M., & Lipin, D. I. (2005). Towards the preparative and large-scale precision manufacture of virus-like particles. Trends in Biotechnology, 23, 523–529.
Sánchez-Rodríguez, S. P., Münch-Anguiano, L., Echeverría, O. M., Vázquez-Nin, G. H., Mora-Pale, M., Dordick, J. S., et al. (2012). Human parvovirus B19 virus-like particles: In vitro assembly and stability. Biochimie, 94, 870–878.
Agbandje-McKenna, M. & Rossmann, M. G. (1997) The structure of human parvovirus B19. In L. J. Anderson & N. S. Young (Eds.) Monographs in Virology. Human Parvovirus B19 (vol. 20) (pp. 3–15). Basel: Karger.
Kaufmann, B., Simpson, A. A., & Rossmann, M. G. (2004). The structure of human parvovirus B19. Proceedings of the National Academy of Sciences of the United States of America, 101, 11628–11633.
Lindner, J., & Modrow, S. (2008). Human bocavirus-a novel parvovirus to infect humans. Intervirology, 51, 116–122.
Servant-Delmas, A., Lefrère, J. J., Morinet, F., & Pillet, S. (2010). Advances in human B19 erythrovirus biology. Journal of Virology, 84, 9658–9665.
Zhi, N., Mills, I. P., Lu, J., Wong, S., Filippone, C., & Brown, K. E. (2006). Molecular and functional analyses of a Human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. Journal of Virology, 80, 5941–5950.
Kajigaya, S., Fujii, H., Field, A., Anderson, S., Rosenfeld, S., Anderson, L. J., et al. (1991). Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proceedings of the National Academy of Sciences of the United States of America, 88, 4646–4650.
Bustos-Jaimes, I., Mora-Lugo, R., Calcagno, M., & Farrés, A. (2010). Kinetic studies of Gly28: Ser mutant form of Bacillus pumilus lipase: Changes in kcat and thermal dependence. BBA Proteins and Proteomics, 1804, 2222–2227.
Lefever, S., Hellemans, J., Pattyn, F., Przybylski, D. R., Taylor, C., Geurts, R., et al. (2009). RDML: structured language and reporting guidelines for real-time quantitative PCR data. Nucleic Acids Research, 37, 2065–2069.
Vaerman, J. L., Sausssoy, P., & Ingargiola, I. (2004). Evaluation of real-time PCR data. Journal of Biological Regulators and Homeostatic Agents, 18, 212–214.
Adams, P. S. (2006) Data analysis and reporting. In M. T. Dorak (Ed) Real-time PCR (pp. 39–62). New York: Taylor & Francis.
Higuchi, R., Fockler, C., Dollinger, G., & Watson, R. (1993). Kinetic PCR analysis: Real time monitoring of DNA amplification reactions. Biotechnology, 11, 1026–1030.
Carrillo-Tripp, M., Shepherd, C. M., Borelli, I. A., Venkataraman, S., Lander, G., Natarajan, P., et al. (2009). VIPERdb2: An enhanced and web API enabled relational database for structural virology. Nucleic Acids Research, 37, D436–D442.
Sánchez-Rodríguez, S. P., Münch-Anguiano, L., & Bustos-Jaimes, I. (2010). Advances in the development of virus-like particles as tools in medicine and nanoscience. Current Chemical Biology, 4, 231–243.
Domingo-Espín, J., Unzueta, U., Saccardo, P., Rodríguez-Carmona, E., Corchero, J. L., Vázquez, E., et al. (2011). Engineered biological entities for drug delivery and gene therapy: Protein nanoparticles. Prog. Mol. Biol. Transl. Sci., 104, 247–298.
Bronstein, L. M. (2011). Virus-based nanoparticles with inorganic cargo: What does the future hold? Small (Weinheim an der Bergstrasse, Germany), 7, 1609–1618.
Gilbert, L., Toivola, J., White, D., Ihalainen, T., Smith, W., Lindholm, L., et al. (2005). Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles. Biochemical and Biophysical Research Communications, 331, 527–535.
Kaufmann, B., Chipman, P. R., Kostyuchenko, V. A., Modrow, S., & Rossmann, M. G. (2008). Visualization of the externalized VP2 N termini of infectious human parvovirus B19. Journal of Virology, 82, 7306–7312.
Brown, C. S., Welling-Wester, S., Feijlbrief, M., Van Lent, J. W. M., & Spaan, W. J. M. (1994). Chimeric Parvovirus B19 capsids for the presentation of foreign epitopes. Virology, 198, 477–488.
Amexis, G., & Young, N. S. (2006). Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of Dengue 2 virus. Journal of Infectious Diseases, 194, 790–794.
Ogasawara, Y., Amexis, G., Yamaguchi, H., Kajigaya, S., Leppla, S. H., & Young, N. S. (2006). Recombinant viral-like particles of parvovirus B19 as antigen carriers of anthrax protective antigen. In Vivo, 20, 319–324.
Ros, C., Baltzer, C., Mani, B., & Kempf, C. (2006). Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability. Virology, 345, 137–147.
Cotmore, S. F., Hafenstein, S., & Tattersall, P. (2010). Depletion of virion associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3′-to-5′ direction from an otherwise intact viral particle. Journal of Virology, 84, 1945–1956.
Bönsch, C., Zuercher, C., Lieby, P., Kempf, C., & Ros, C. (2010). The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization. Journal of Virology, 84, 11737–11746.
Aposhian, H. V., Thayer, R. E., & Qasba, P. K. (1975). Formation of nucleoprotein complexes between Polyoma empty capsids and DNA. Journal of Virology, 15, 645–653.
Barr, S. M., Keck, K., & Aposhian, H. V. (1979). Cell-free assembly of a polyoma-like particle from empty capsids and DNA. Virology, 96, 656–659.
Krauzewicz, N., Stokrová, J., Jenkins, C., Elliott, M., Higgins, C. F., & Griffin, B. E. (2000). Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids. Gene Therapy, 7, 2122–2131.
Stokrová, J., Palková, Z., Fischer, L., Richterová, Z., Korb, J., Griffin, B. E., et al. (1999). Interactions of heterologous DNA with polyomavirus major structural protein, VP1. FEBS Letters, 445, 119–125.
Tibbetts, C., & Giam, C. Z. (1979). In vitro association of empty adenovirus capsids with double-stranded DNA. Journal of Virology, 32, 995–1005.
Goldmann, C., Stolte, N., Nisslein, T., Hunsmann, G., Lüke, W., & Petry, H. (2000). Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus. Journal of Virological Methods, 90, 85–90.
Bartel, D. P. (2009). MicroRNA target recognition and regulatory functions. Cell, 136, 215–233.
Grijalvo, S., Aviñó, A., & Eritja, R. (2014). Oligonucleotide delivery: A patent review (2010–2013). Expert Opinion on Therapeutic Patents, 24, 801–819.
Acknowledgments
This work was funded by Consejo Nacional de Ciencia y Tecnología (CONACyT), México (Grant CB-2010-01-151189) and Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM (Grant IN215613). The authors acknowledge technical support of Laura Álvarez-Añorve.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sánchez-Rodríguez, S.P., Enrriquez-Avila, J.V., Soto-Fajardo, J.M. et al. In Vitro Encapsulation of Heterologous dsDNA Into Human Parvovirus B19 Virus-Like Particles. Mol Biotechnol 57, 309–317 (2015). https://doi.org/10.1007/s12033-014-9823-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-014-9823-4